URS
SGMT icon

Utah Retirement Systems’s Sagimet Biosciences SGMT Stock Holding History

Utah Retirement Systems’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-54,283
Closed -$177K – 998
2025
Q1 		$177K Buy
54,283
+28,200
+108% +$118K ﹤0.01% 942
2024
Q4 		$117K Hold
26,083
– – ﹤0.01% 964
2024
Q3 		$72.3K Hold
26,083
– – ﹤0.01% 981
2024
Q2 		$89.2K Hold
26,083
– – ﹤0.01% 963
2024
Q1 		$141K Buy
+26,083
New +$187K ﹤0.01% 950

Other funds holding SGMT

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.23B AUM 15% 1-Year Est. Return

Utah Retirement Systems's SGMT Position: Q2 2025 in Review

Utah Retirement Systems sold out of Sagimet Biosciences (SGMT) in Q2 2025, closing a stake of 54,283 shares — an estimated $177K sold.

Utah Retirement Systems first reported a position in SGMT in Q1 2024 and held it in 5 quarters. The position peaked at $177K in Q1 2025. 67 funds tracked by Wall St. Rank hold SGMT as of Q2 2025.

  • Utah Retirement Systems reported no remaining Sagimet Biosciences position as of Q2 2025 after selling out during the quarter.
  • Utah Retirement Systems sold 54,283 Sagimet Biosciences shares in Q2 2025, an estimated $177K.
  • Utah Retirement Systems first reported a position in Sagimet Biosciences in Q1 2024 and held it in 5 quarters.
  • Utah Retirement Systems's Sagimet Biosciences position peaked at $177K in Q1 2025.
  • 67 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2025.

Based on Utah Retirement Systems's 13F filing for Q2 2025, filed 14 Aug 2025.